Evolus, Inc. share price logo

Evolus, Inc. Share Price

NASDAQ: EOLS

Small Cap

$6.92

-0.28

(-3.82%)

Live

as on

Evolus, Inc. Stock Performance

as on September 15, 2025 at 10:41 pm IST

  • Day's High

    $6.92
    $7.27

    5.06%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.71
    $17.82
    downward going graph

    17.49%

    Downside

    157.51%

    Upside

    downward going graph

Evolus, Inc. share price movements today

Previous Close
$7.19
Open
$7.25
Volume
729.5K
Day's Low - High
$6.92 - $7.27
52 Week Low - High
$5.71 - $17.82

Evolus, Inc. Historical Returns

1 Month Return
+ 9.21 %
3 Month Return
-25.98 %
1 Year Return
-57.98 %
3 Year Return
-27.66 %
5 Year Return
+ 100.82 %

Evolus, Inc. Stock Fundamentals & Key Indicators

Check Evolus, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$465.1M

EPS (TTM)

-0.552

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-18.77

Industry PE ratio

-3.8535542168674697

P/B Ratio

0

PEG Ratio

0

EBITDA

-35.2M

Revenue (TTM)

277.9M

Profit Margin

-22.31%

Return On Equity TTM

33000.00%

Evolus, Inc. Stock Valuation

Track how Evolus, Inc. P/E has moved over time to understand its valuation trends.

Evolus, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Today (-18.77x)

September 15, 2025

Industry (-3.85x)

September 15, 2025

Highest (0.00x)

September 15, 2025

LowHigh

Today’s Price to Earnings Ratio: -18.77x

Evolus, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evolus, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$465.1M100.82%-18.77-22.31%
BUY$18.3BNA15.840.36%
BUY$44.1BNA21.813.81%
BUY$14.1B36.02%41.9713.88%
BUY$65.7B-8.68%25.5127.83%

Stock Returns calculator for Evolus, Inc. Stock including INR - Dollar returns

The Evolus, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Evolus, Inc. investment value today

Current value as on today

₹44,551

Returns

₹55,449

(-55.45%)

Returns from Evolus, Inc. Stock

₹60,435 (-60.43%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Evolus, Inc. Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Evolus, Inc.. Average target price of $18.83

Evolus, Inc. Share Price Target

Get share price movements and forecasts by analysts on Evolus, Inc..

What analysts predicted

63.25%UPSIDE

Target Price

$18.83

Current Price

$6.92

Analyzed by

14 Analysts

Target

$18.83

Evolus, Inc. target price $18.83, a slight upside of 63.25% compared to current price of $6.92. According to 14 analysts rating.

Evolus, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
41
49
49
60
59
66
61
78
68
69
Gross Profit
29
34
33
40
39
46
42
50
46
45
Operating Income
-10
-15
-13
-5
-7
-6
-15
-2
-15
-10
EBITDA
-10
-13
-11
-6
-6
-5
-13
-3
-12
-7
Interest Expense
2
3
3
4
4
4
4
4
4
7
Depreciation
1
1
1
1
1
1
1
1
1
2
Income Before Tax
-14
-18
-16
-11
-13
-11
-19
-6
-18
-17
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-14
-18
-16
-11
-13
-11
-19
-6
-18
-17
Net Profit Margin
-35.45%
-36.76%
-34.31%
-19.40%
-22.09%
-16.96%
-31.38%
-8.60%
-27.75%
-24.70%

Evolus, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
34
56
99
148
202
266
Gross Profit
0
0
0
-
26
38
56
92
140
182
Operating Income
-30
-19
-11
-46
-94
-68
-63
-57
-49
-34
EBITDA
-30
-19
-11
-45
-92
-144
-39
-60
-41
-25
Interest Expense
-
-
-
0
7
10
1
9
13
18
Depreciation
-
-
0
0
5
7
6
4
5
6
Income Before Tax
-31
-19
-11
-46
-105
-162
-46
-74
-61
-49
Income Tax Expense
0
0
-7
0
-15
0
0
0
0
0
Net Income
-31
-20
-4
-46
-90
-163
-46
-74
-61
-50
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-257.79%
-288.31%
-46.96%
-50.07%
-30.52%
-18.94%

Evolus, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-18
0
-11
-13
-11
-19
-6
-18
0
Operating Cash Flow
-13
-34
0
-10
-6
-5
4
-15
-24
Investing Cash Flow
0
-1
0
0
-1
-1
-1
-1
-
Financing Cash Flow
23
21
23
45
4
-1
-1
-1
20
Change in Cash
10
-15
24
34
-3
-8
1
-19
-6

Evolus, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-20
-4
-46
-90
-163
-46
-74
-61
-50
Operating Cash Flow
-13
-13
-25
-93
-57
-33
-8
-34
-17
Investing Cash Flow
0
0
0
-23
12
4
-1
-1
-4
Financing Cash Flow
13
13
118
133
38
73
-1
44
47
Change in Cash
0
0
93
16
-7
43
-11
8
24

Global Institutional Holdings in Evolus, Inc.

Funds
Holdings
TANG CAPITAL MANAGEMENT LLC
7.73%
BlackRock Inc
6.69%
Perceptive Advisors LLC
6.39%
Nantahala Capital Management, LLC
5.65%
Vanguard Group Inc
5%

Insights on Evolus, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 68.07M → 69.38M (in $), with an average increase of 1.9% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -18.89M → -17.14M (in $), with an average increase of 10.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 83.6% return, outperforming this stock by 112.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 19.4% return, outperforming this stock by 78.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, EOLS stock has moved down by -5.5%

About Evolus, Inc.

evolus, inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the united states. it offers jeuveau, a proprietary 900 kilodalton purified botulinum toxin type a formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. the company was founded in 2012 and is headquartered in newport beach, california.
OrganisationEvolus, Inc.
Headquarters520 Newport Center Drive, Newport Beach, CA, United States, 92660
IndustryHealth Technology
CEOMr. David Moatazedi
E-voting on sharesClick here to vote

Key Management of Evolus, Inc.

Name

Title

Ms. Tomoko Yamagishi-Dressler

Chief Marketing Officer

Dr. Rui Avelar C.CFP, Dip.SportMed, M.D.

Chief Medical Officer and Head of Research & Development

Ms. Tatjana Mitchell

Chief Financial Officer

Mr. Nareg Sagherian

Head of Global Investor Relations & Corporate Communications

Mr. Jeffrey J. Plumer

General Counsel

Mr. Kurt Knab

Senior Vice President of Sales

Ms. Jessica Novak

Senior Vice President of Human Resources

Mr. David Moatazedi

President, CEO & Director

FAQs

What is Evolus, Inc. share price today?

Evolus, Inc. share price today is $6.92 as on . Evolus, Inc. share today touched a day high of $7.27 and a low of $6.92.

What is the 52 week high and 52 week low for Evolus, Inc. share?

Evolus, Inc. share touched a 52 week high of $17.82 on and a 52 week low of $5.71 on . Evolus, Inc. stock price today i.e. is trending at $6.92,which is 61.17% down from its 52 week high and 21.19% up from its 52 week low.

What is Evolus, Inc.'s market capitalisation today?

Evolus, Inc. market capitalisation is $0.00T as on .

How to invest in Evolus, Inc. Stock (EOLS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evolus, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evolus, Inc. Shares that will get you 0.2168 shares as per Evolus, Inc. share price of $6.92 per share as on September 15, 2025 at 10:41 pm IST.

What is the minimum amount required to buy Evolus, Inc. Stock (EOLS) from India?

Indian investors can start investing in Evolus, Inc. (EOLS) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Evolus, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Evolus, Inc. share’s latest price of $6.92 as on September 15, 2025 at 10:41 pm IST, you will get 1.4451 shares of Evolus, Inc.. Learn more about fractional shares .

What are the returns that Evolus, Inc. has given to Indian investors in the last 5 years?

Evolus, Inc. stock has given 100.82% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?